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Background
HTLV-I and –II (HTLV-I/II) infection is prevalent at
low levels in the United States, but recent reports on
HTLV-I/II prevalence among blood donors are lacking.
Methods
Computerized data on all first-time blood donors in a
large network of United States blood centers was exam-
ined during the period 2000-2009. HTLV-I/II antibody
was measured by enzyme immunoassay (EIA), with sup-
plemental testing of all reactive samples using an EIA
from an alternate manufacturer. Prevalence rates were
calculated, and odds ratios (OR) and 95% confidence
intervals (CI) for associations with demographic charac-
teristics were assessed using multivariate logistic
regression.
Results
Among 1,904,155 first-time blood donors, HTLV-I/II
prevalence decreased from 10 per 10,000 in 2000 to 5
per 10,000 in 2009 (p trend < 0.0001). Prevalence
increased with age through middle age and then
decreased in older age. HTLV-I/II infection was asso-
ciated with female sex (OR =1.54, 95% CI 1.28-1.85),
age 50-59 (OR=10.15, 95% CI 6.16-16.72), Black
(OR=5.69, 95% CI 4.38-7.38) and Hispanic (OR=2.59,
95% CI 2.06-3.26) race/ethnicity, and inversely with uni-
versity education (OR=0.59, 95% CI 0.45-0.76). There
was minimal geographic variation, although donors from
the southwestern US had slightly higher prevalence.
Conclusions
HTLV-I/II prevalence is decreasing slowly among US
blood donors, consistent with a birth cohort effect
whereby donors born in the 1950s and 60s had higher
prevalence rates compared to younger donors. HTLV-I/
II associations with female sex, non-white race and
lower educational achievement are consistent with pre-
vious studies. With 3.2 million first-time donors
annually nationwide, US blood banks detect several hun-
dred HTLV-I/II infections per year.
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